Ketoconazole doubles the AUC of
rimonabant. Other
azoles that are potent inhibitors of CYP3A4, such as
itraconazole, are predicted to interact similarly.
The manufacturers of
rimonabant recommend caution. Monitor for signs of increased
rimonabant adverse effects.